Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Keywords:
With patent expirations and loss of revenues for pharmaceutical manufacturers, a flurry of deals is taking place.
Grouped Articles
Goldman Hits Mother Lode on Deals
Wall Street Journal 11/18/2014
No Miracle Cure From Pharmaceutical Mergers
Wall Street Journal 04/07/2012
Grouped Articles
Indian Drugmakers Target Niche Markets
Wall Street Journal 04/19/2016
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
Indian Companies Hit Their Stride
BusinessWeek 09/17/2007
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
No Miracle Cure From Pharmaceutical Mergers
Wall Street Journal 04/07/2012
Grouped Articles
F.D.A. Approves Pill to Treat Hepatitis C
New York Times 12/06/2013
Gilead’s Hepatitis C Drug, Sovaldi, Is on Pace to Become a Blockbuster
New York Times 07/23/2014
Gilead to Allow Cheaper Hepatitis C Drug in Developing Countries
Wall Street Journal 09/16/2014
Overheard: Gilead Needs More Tracks
Wall Street Journal 02/22/2015
Wall Street Journal 11/22/2011
Gilead's Risky Revival Procedure
Wall Street Journal 11/22/2011
Grouped Articles
Bausch & Lomb Nears Deal to Sell Itself to Valeant for $9 Billion
Wall Street Journal 05/25/2013
Spurned Last Year, Valeant Resumes Deal-Making
New York Times 02/22/2015
Valeant Bears Get Some Satisfaction
Wall Street Journal 10/16/2015
Valeant, Under Pressure About Price Increases, Plans Changes
Wall Street Journal 10/20/2015
Valeant Rebuts Critical Report That Pummels Stock
Wall Street Journal 10/22/2015
Wall Street Journal 07/27/2011
Grouped Articles
Roche Offers $5.7 Billion for Gene Company Illumina
Wall Street Journal 01/25/2012
No Miracle Cure From Pharmaceutical Mergers
Wall Street Journal 04/07/2012
Roche to Acquire Ventana for $3.4 Billion
Wall Street Journal 01/23/2008
As growth slows pharmaceutical companies look to acquisitions for growth and new drugs.
Grouped Articles
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
BusinessWeek 12/05/2007
CEO Says Aging Population Part of Allure of Eye-Care Acquisition
Wall Street Journal 04/08/2008
Wall Street Journal 01/24/2009
Wall Street Journal 03/02/2009
For Drug Deals, Small Is Beautiful
Wall Street Journal 03/12/2009
Grouped Articles
Indian Drugmakers Target Niche Markets
Wall Street Journal 04/19/2016
Wall Street Journal 09/27/2011
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
No Miracle Cure From Pharmaceutical Mergers
Wall Street Journal 04/07/2012
Wall Street Journal 04/26/2012
Swiss pharmaceuticals company that acquired Genetech.
Grouped Articles
Roche to Acquire Ventana for $3.4 Billion
Wall Street Journal 01/23/2008
Roche Offers to Buy Full Stake in Genentech
Wall Street Journal 07/22/2008
Roche Bid Blindsided Genentech
Wall Street Journal 07/22/2008
Roche Chief Warns of a Likely Shakeout
Wall Street Journal 12/08/2008
Economist 12/10/2009
Can Roche Leave Genentech Alone?
BusinessWeek 11/25/2009
Grouped Articles
Alcon Deal Puts Novartis in a Bind
Wall Street Journal 06/15/2009
Novartis Sets Big Eye-Care Deal
Wall Street Journal 01/05/2010
Novartis to Pay $28 Billion for a Majority Stake in Alcon
New York Times 01/05/2010
Novartis Seals Purchase of Big Alcon Stake
Wall Street Journal 08/27/2010
Wall Street Journal 09/13/2011
No Miracle Cure From Pharmaceutical Mergers
Wall Street Journal 04/07/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1